Abstract Human Immunodeficiency Virus (HIV)-induced anemia remains a significant
hematological complication, contributing to morbidity and complicating the management of …

Abstract Human Immunodeficiency Virus (HIV) remains a global health concern,
necessitating multifaceted approaches to improve patient outcomes. While antiretroviral …

The dynamic interplay between CD4 and CD8 T-cell populations stands as a pivotal aspect
of immune function, particularly in the context of HIV infection. The balance between CD4 …

HIV infection during pregnancy introduces unique challenges to maternal-fetal health,
influencing the intricate dynamics of placental tissues. Eosinophilic changes, characterized …

Erythropoietin (EPO) therapy has emerged as a promising avenue in addressing anemia
associated with HIV infection, a prevalent and clinically significant complication. This critical …

Antiretroviral therapy (ART) has significantly improved the prognosis of HIV-infected
individuals, yet concerns persist regarding its impact on platelet function and subsequent …

Antiretroviral therapy (ART) has transformed the landscape of HIV/AIDS management,
significantly improving patient outcomes. However, the impact of ART on platelet …

HIV infection is characterized by dysregulated immune cell trafficking, contributing to chronic
immune activation, inflammation, and disease progression. L-selectin, a key adhesion …

Platelet activation and dysregulation of cell adhesion molecules, particularly P-Selectin, play
pivotal roles in the pathogenesis of human immunodeficiency virus (HIV) infection …

HIV infection leads to progressive immune dysfunction characterized by T cell exhaustion, a
state of functional impairment and loss of effector functions. L-selectin, a key adhesion …